chitosan has been researched along with Ischemia in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (11.76) | 29.6817 |
| 2010's | 9 (52.94) | 24.3611 |
| 2020's | 6 (35.29) | 2.80 |
| Authors | Studies |
|---|---|
| Aleksandrov, IV; Evreinova, NV; Galagudza, MM; Istomina, MS; Korolev, DV; Krasichkov, AS; Postnov, VN; Shulmeyster, GA; Syrovatkina, MS | 1 |
| Ataullakhanov, FI; Guan, X; Han, Q; Ke, Y; Liu, L; Ma, Z; Meng, W; Panteleev, M; Shi, Q; Xia, Y; Xiang, Z; Ye, H; Zhang, T | 1 |
| Cao, Y; Dong, H; Dong, X; Gong, J; Han, B; Jin, S; Liu, J; Shi, W; Tan, X; Wang, Z; Xiang, F; Yin, S; Zhang, G; Zhang, N; Zhang, S; Zhao, X | 1 |
| Bushkalova, R; Cussac, D; Duployer, B; Farno, M; Girod Fullana, S; Parini, A; Sallerin, B; Tenailleau, C | 1 |
| Guo, Y; Hu, B; Hu, H; Liu, H; Yang, H; Yao, X; Zheng, J; Zhu, L | 1 |
| Aliakbari, S; Farokhi, M; Gholizadeh, SS; Hosseini, SM; Jafari, SH; Naderi, N; Nourbakhsh, M; Pourbadie, HG; Ramsey, JD; Saeb, MR; Thomas, S; Zarrintaj, P; Zibaii, MI | 1 |
| Dai, K; Gao, Z; Liu, C; Shen, T; Tang, W; Wang, J; Yu, Y; Yuan, Y | 1 |
| Cui, B; Cui, J; Guo, Z; Han, Z; Han, ZC; He, ZX; Li, Z; Qi, X; Song, X; Yao, Y; Yue, Z; Zhao, N | 1 |
| Bellamkonda, RV; Byun, J; Kim, S; Lee, G; Lee, S; Mokarram, N; Pai, SB; Um, E; Valmikinathan, CM; Yoon, YS | 1 |
| Albrecht-Schgoer, K; Barthelmes, J; Bernkop-Schnürch, A; Dünnhaupt, S; Gutmann, C; Kirchmair, R; Lener, D; Nardin, I; Schgoer, W; Theurl, M | 1 |
| Cheong, SJ; Jeong, HJ; Kim, DW; Kim, EM; Lee, CM; Lim, ST; Sohn, MH | 1 |
| Alonso, MJ; D'Angelo, I; Garcia-Fuentes, M; Parajó, Y; Welle, A | 1 |
| Hodges, SJ; Jennell, JL; Washburn, S | 1 |
| Akduman, B; Aydın Mungan, N; Bektaş, S; Erol, B; Hakimolu, S; Hancı, V; Karakaya, K; Tokgöz, H | 1 |
| Barry, FP; Duffy, GP; Hastings, CL; Kelly, HM; Murphy, MJ; O'Brien, FJ | 1 |
| Bernas, G | 1 |
| Amano, Y; Aoki, H; Hattori, H; Ishihara, M; Ishizuka, T; Kanatani, Y; Kishimoto, S; Kiyosawa, T; Maehara, T; Nakamura, S; Nambu, M; Takase, B | 1 |
1 review(s) available for chitosan and Ischemia
| Article | Year |
|---|---|
Angiotherapeutics from natural products: from bench to clinics?
Topics: Angiogenesis Inducing Agents; Angiogenesis Inhibitors; Animals; Biological Products; Chitin; Chitosan; Drug Evaluation, Preclinical; Forecasting; Humans; Ischemia; Neoplasms; Neovascularization, Pathologic; Neovascularization, Physiologic; Rabbits | 2003 |
16 other study(ies) available for chitosan and Ischemia
| Article | Year |
|---|---|
Theranostic Platforms Based on Silica and Magnetic Nanoparticles Containing Quinacrine, Chitosan, Fluorophores, and Quantum Dots.
Topics: Chitosan; Early Diagnosis; Fluorescent Dyes; Humans; Ischemia; Magnetite Nanoparticles; Molecular Structure; Nanoparticles; Precision Medicine; Quantum Dots; Quinacrine; Silicon Dioxide; Theranostic Nanomedicine | 2022 |
Phenylboronic Ester-Bridged Chitosan/Myricetin Nanomicelle for Penetrating the Endothelial Barrier and Regulating Macrophage Polarization and Inflammation against Ischemic Diseases.
Topics: Antioxidants; Chitosan; Endothelium; Humans; Inflammation; Ischemia; Macrophages; Reactive Oxygen Species; Reperfusion Injury | 2023 |
Chitosan oligosaccharide attenuates acute kidney injury and renal interstitial fibrosis induced by ischemia-reperfusion.
Topics: Acute Kidney Injury; Chitosan; Fibrosis; Humans; Ischemia; Kidney; Oligosaccharides; Reperfusion; Reperfusion Injury | 2023 |
Alginate-chitosan PEC scaffolds: A useful tool for soft tissues cell therapy.
Topics: Alginates; Animals; Biocompatible Materials; Cell Proliferation; Cell Survival; Cells, Cultured; Chitosan; Combined Modality Therapy; Disease Models, Animal; Feasibility Studies; Female; Humans; Ischemia; Male; Materials Testing; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Polyelectrolytes; Porosity; Primary Cell Culture; Rats; Rats, Inbred Lew; Tissue Engineering; Tissue Scaffolds | 2019 |
Effect of Chitosan oligosaccharides on ischemic symptom and gut microbiota disbalance in mice with hindlimb ischemia.
Topics: Animals; Chitosan; Femoral Artery; Gastrointestinal Microbiome; Hindlimb; Inflammation; Ischemia; Male; Mice; Mice, Inbred C57BL; Muscle, Skeletal; Neovascularization, Physiologic; Oxidative Stress; Regional Blood Flow | 2020 |
Fabricating an electroactive injectable hydrogel based on pluronic-chitosan/aniline-pentamer containing angiogenic factor for functional repair of the hippocampus ischemia rat model.
Topics: Angiogenesis Inducing Agents; Aniline Compounds; Animals; Chitosan; Hippocampus; Hydrogels; Ischemia; Rats | 2020 |
Sulfated polysaccharide directs therapeutic angiogenesis via endogenous VEGF secretion of macrophages.
Topics: Angiogenesis Inducing Agents; Animals; Biocompatible Materials; Chitosan; Ischemia; Macrophages; Mice; Neovascularization, Physiologic; Polysaccharides; Sulfates; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2; Vascular Endothelial Growth Factors | 2021 |
IGF-1C domain-modified hydrogel enhances therapeutic potential of mesenchymal stem cells for hindlimb ischemia.
Topics: Animals; Apoptosis; Cell Survival; Chitosan; Female; Hindlimb; Humans; Hydrogels; Hydrogen Peroxide; Insulin-Like Growth Factor I; Ischemia; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Mice; Mice, Transgenic; Neovascularization, Physiologic; Placenta; Pregnancy | 2019 |
Enhanced therapeutic neovascularization by CD31-expressing cells and embryonic stem cell-derived endothelial cells engineered with chitosan hydrogel containing VEGF-releasing microtubes.
Topics: Animals; Cells, Cultured; Chitosan; Embryonic Stem Cells; Endothelial Cells; Hindlimb; Hydrogel, Polyethylene Glycol Dimethacrylate; Ischemia; Male; Mice; Neovascularization, Physiologic; Platelet Endothelial Cell Adhesion Molecule-1; Tissue Scaffolds; Vascular Endothelial Growth Factor A | 2015 |
Nanoparticular delivery system for a secretoneurin derivative induces angiogenesis in a hind limb ischemia model.
Topics: Angiogenesis Inducing Agents; Animals; Apoptosis; Cell Proliferation; Chitosan; Chromatography, High Pressure Liquid; Drug Delivery Systems; Endothelium, Vascular; Hindlimb; Human Umbilical Vein Endothelial Cells; Humans; Ischemia; Mice; Muscle, Skeletal; Nanoparticles; Neovascularization, Physiologic; Neuropeptides; Particle Size; Peripheral Arterial Disease; Secretogranin II | 2017 |
Targeted molecular imaging of VEGF receptors overexpressed in ischemic microvasculature using chitosan-DC101 conjugates.
Topics: Animals; Antibodies, Monoclonal; Carbocyanines; Cells, Cultured; Chitosan; Female; Hindlimb; Humans; Ischemia; Mice; Mice, Inbred BALB C; Microvessels; Molecular Imaging; Muscle, Skeletal; Neovascularization, Physiologic; Protein Isoforms; Radionuclide Imaging; Receptors, Vascular Endothelial Growth Factor; Technetium | 2010 |
Hyaluronic acid/Chitosan nanoparticles as delivery vehicles for VEGF and PDGF-BB.
Topics: Animals; Becaplermin; Biocompatible Materials; Carcinoma, Hepatocellular; Cattle; Cell Line, Tumor; Chitosan; Drug Carriers; Drug Delivery Systems; Excipients; Heparin; Humans; Hyaluronic Acid; Ischemia; Nanoparticles; Neovascularization, Physiologic; Platelet-Derived Growth Factor; Proto-Oncogene Proteins c-sis; Serum Albumin, Bovine; Tissue Engineering; Transplants; Vascular Endothelial Growth Factor A | 2010 |
Halofuginone- and chitosan-coated amnion membranes demonstrate improved abdominal adhesion prevention.
Topics: Abdomen; Amnion; Angiogenesis Inhibitors; Animals; Cellulose, Oxidized; Chitosan; Female; Ischemia; Laparotomy; Piperidines; Postoperative Complications; Quinazolinones; Random Allocation; Rats; Rats, Sprague-Dawley; Tissue Adhesions; Treatment Outcome; Uterine Diseases; Uterus | 2010 |
Postoperative adhesions after application of topical hemostatic agents: outcomes in a rat partial nephrectomy model.
Topics: Administration, Topical; Animals; Cellulose; Chitosan; Hematoma; Hemostasis; Hemostatic Techniques; Hemostatics; Ischemia; Kidney; Male; Nephrectomy; Oxygen; Plant Extracts; Postoperative Complications; Rats; Rats, Wistar; Tissue Adhesions; Wound Healing | 2011 |
Development of a thermoresponsive chitosan gel combined with human mesenchymal stem cells and desferrioxamine as a multimodal pro-angiogenic therapeutic for the treatment of critical limb ischaemia.
Topics: Angiogenesis Inducing Agents; Cell Movement; Cell Proliferation; Cells, Cultured; Chitosan; Deferoxamine; Delayed-Action Preparations; Extremities; Glycerophosphates; Human Umbilical Vein Endothelial Cells; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Ischemia; Mesenchymal Stem Cells; Neovascularization, Physiologic; Rheology; Temperature | 2012 |
Effect of controlled release of fibroblast growth factor-2 from chitosan/fucoidan micro complex-hydrogel on in vitro and in vivo vascularization.
Topics: Animals; Chitosan; Delayed-Action Preparations; Drug Carriers; Fibroblast Growth Factor 2; Half-Life; Hydrogel, Polyethylene Glycol Dimethacrylate; Ischemia; Mice; Neovascularization, Physiologic; Polysaccharides | 2008 |